Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-04-14 | Deirdre P. Connelly, Age 55, Director since 2016, Member of Audit and Corporate Governance Committees. Compensation: $151,842 in 2016. |
| 2018-04-13 | Deirdre P. Connelly AGE:57DIRECTOR SINCE:2016 Member, Audit and Corporate Governance Committees ... COMPENSATION OF NON-EMPLOYEE DIRECTORS* DURING 2017 Deirdre P. Connelly FEES EARNED OR PAID IN CASH: 110,000 STOCK AWARDS: 161,000 TOTAL: 271,000 |
| 2019-04-12 | Deirdre P. Connelly AGE:58 DIRECTOR SINCE:2016 Member, Audit and Corporate Governance Committees COMPENSATION OF NON-EMPLOYEE DIRECTORS Deirdre P. Connelly FEES EARNED OR PAID IN CASH: 110,000 STOCK AWARDS: 161,000 TOTAL: 271,000 |
| 2020-04-24 | Age: 59 Director since: 2016 Chair, Corporate Governance Committee Member, Audit Committee ... Deirdre P. Connelly Retired President, North American Pharmaceuticals of GlaxoSmithKline ... Compensation of Non-Employee Directors* during 2019 Deirdre P. Connelly Fees earned or paid in cash: 128,069 Stock awards: 165,000 Total: 293,069 |
| 2021-04-16 | Retired President, North American Pharmaceuticals of GlaxoSmithKline |
| 2022-04-14 | Age: 61 Director since: 2016 Chair, Corporate Governance Committee Member, Audit Committee ... Compensation of Non-Employee Directors ... Deirdre P. Connelly ... Total 305,000 |
| 2023-04-13 | Deirdre P. Connelly Age: 62 Director since: 2016 Chair, Corporate Governance Committee Member, Audit Committee Independent Director Compensation: $305,000 |
| 2024-04-11 | Age: 63 Independent Director since:2016 Chair, Corporate GovernanceCommittee Member, Audit,Compensation and ExecutiveCommittees Compensation of Non-Employee Directors During 2023: Deirdre P. Connelly 305,000 |
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-01 | Ms. Connelly has many years of leadership experience and expertise as a senior executive of large publicly-traded companies with global operations. She has extensive knowledge and expertise in strategy, operations, product development, brand marketing and merchandising. In addition, as a former Human Resources executive, Ms. Connelly also has valuable insight in managing a large-scale, diverse workforce. |
| 2016-03-30 | Former President, North American Pharmaceuticals of GlaxoSmithKline; extensive knowledge in strategy, operations, product development, brand marketing and merchandising. |
| 2017-03-31 | Former President, North American Pharmaceuticals of GlaxoSmithKline; extensive knowledge and expertise in strategy, operations, product development, brand marketing and merchandising. |
| 2018-04-04 | Former President, North American Pharmaceuticals of GlaxoSmithKline ... extensive knowledge and expertise in strategy, operations, product development, brand marketing and merchandising. |
| 2019-04-03 | Former President, North American Pharmaceuticals of GlaxoSmithKline |
| 2020-04-01 | Ms. Connelly has many years of leadership experience as a senior executive of large publicly-traded companies with global operations. She has extensive knowledge and expertise in strategy, operations, product development, brand marketing and merchandising. In addition, as a former Human Resources executive, Ms. Connelly also has valuable insight in managing a large-scale, diverse workforce. |
| 2021-04-06 | Former President, North American Pharmaceuticals of GlaxoSmithKline; extensive leadership but no technical background. |
| 2022-04-01 | Former President, North American Pharmaceuticals of GlaxoSmithKline ... extensive knowledge and expertise in strategy, operations, product development, brand marketing, merchandising, risk management and compensation/benefits oversight. |
| 2023-04-03 | Ms. Connelly possesses leadership experience as a senior executive of large publicly traded companies with global operations. In addition, as a former Human Resources executive, Ms. Connelly has valuable insight in compensation/benefits oversight and managing a large-scale, diverse workforce along with experience in identifying, assessing and managing risk exposure at public companies. |
| 2024-04-15 | Ms. Connelly possesses many years of leadership experience as a senior executive of large publicly traded companies with global operations. Notably, she served in senior leadership roles at global pharmaceutical companies including Eli Lilly, where her responsibilities included leading an R&D global product development organization. |
| 2025-04-01 | Ms. Connelly led an R&D global product development organization at Eli Lilly and Co-Chaired the Global Product Investment Board at GlaxoSmithKline for six years. |
Data sourced from SEC filings. Last updated: 2025-07-01